GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Resources Pharmaceutical Group Ltd (HKSE:03320) » Definitions » Price-to-Operating-Cash-Flow

China Resources Pharmaceutical Group (HKSE:03320) Price-to-Operating-Cash-Flow : 2.28 (As of May. 20, 2024)


View and export this data going back to 2016. Start your Free Trial

What is China Resources Pharmaceutical Group Price-to-Operating-Cash-Flow?

As of today (2024-05-20), China Resources Pharmaceutical Group's share price is HK$6.17. China Resources Pharmaceutical Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2.71. Hence, China Resources Pharmaceutical Group's Price-to-Operating-Cash-Flow Ratio for today is 2.28.

The historical rank and industry rank for China Resources Pharmaceutical Group's Price-to-Operating-Cash-Flow or its related term are showing as below:

HKSE:03320' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.73   Med: 3.79   Max: 16.44
Current: 2.29

During the past 11 years, China Resources Pharmaceutical Group's highest Price-to-Operating-Cash-Flow Ratio was 16.44. The lowest was 1.73. And the median was 3.79.

HKSE:03320's Price-to-Operating-Cash-Flow is ranked better than
96.9% of 677 companies
in the Drug Manufacturers industry
Industry Median: 17.76 vs HKSE:03320: 2.29

China Resources Pharmaceutical Group's Cash Flow from Operations per share for the six months ended in Dec. 2023 was HK$3.40. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2.71.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of China Resources Pharmaceutical Group was 40.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 27.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 16.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 14.40% per year.

During the past 11 years, China Resources Pharmaceutical Group's highest 3-Year average Operating Cash Flow per Share Growth Rate was 27.50% per year. The lowest was 4.00% per year. And the median was 14.75% per year.


China Resources Pharmaceutical Group Price-to-Operating-Cash-Flow Historical Data

The historical data trend for China Resources Pharmaceutical Group's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Resources Pharmaceutical Group Price-to-Operating-Cash-Flow Chart

China Resources Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.58 3.06 1.74 3.29 1.90

China Resources Pharmaceutical Group Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.74 - 3.29 - 1.90

Competitive Comparison of China Resources Pharmaceutical Group's Price-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, China Resources Pharmaceutical Group's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Resources Pharmaceutical Group's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Resources Pharmaceutical Group's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where China Resources Pharmaceutical Group's Price-to-Operating-Cash-Flow falls into.



China Resources Pharmaceutical Group Price-to-Operating-Cash-Flow Calculation

China Resources Pharmaceutical Group's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=6.17/2.707
=2.28

China Resources Pharmaceutical Group's Share Price of today is HK$6.17.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. China Resources Pharmaceutical Group's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$2.71.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

China Resources Pharmaceutical Group Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of China Resources Pharmaceutical Group's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


China Resources Pharmaceutical Group (HKSE:03320) Business Description

Traded in Other Exchanges
Address
26 Harbour Road, 41st Floor, China Resources Building, Room 4104-05, Wanchai, HKG
CR Pharma, is a vertically integrated conglomerate that operates drug manufacturing, distribution, and retail pharmacy businesses in mainland China. It is the third largest drug distributor by revenue, with a strong presence in Eastern, Northern, and Southern China. Its drug manufacturing segment primarily consists of four listed subsidiaries, Dong E E Jiao, CR Sanjiu, CR Double Crane, and Jiangzhong Pharmaceutical, which are well-known makers of over-the-counter traditional Chinese medicines (or TCM), health supplements, and prescription drugs. We estimate the company's operating income is approximately 53% distribution, 46% manufacturing, and less than 1% retail pharmacies.

China Resources Pharmaceutical Group (HKSE:03320) Headlines

No Headlines